United Airlines operates a fleet of 53 Boeing 767 aircraft, of which 37 are the 767-300ER variants, with an average age of 29 ...

The new Halifax-Amsterdam service is part of a broader expansion of WestJet’s transatlantic operations from YHZ. The airline will also restore service to Paris Charles de Gaulle Airport in summer 2025 ...

At the heart of this transformation is the adoption of the IATA ONE Order standard, which will elevate the customer experience to meet the evolving needs of digitally savvy consumers.

KLM is based in the Netherlands, and so these 5th freedom flights connect cities outside of this country. To invoke 5th freedom rights, airlines must have permission from both foreign countries as ...

SimpleFlying Few & Far Between: KLM's Three 5th Freedom Routes Posted: February 7, 2025 | Last updated: February 7, 2025 KLM is based in the Netherlands, and so these 5th freedom flights connect ...

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Exelixis (EXEL) and Techne (TECH). But which of these two stocks is more attractive ...

Free route airspace (FRA) is a specified airspace within which users may freely plan a route between a defined entry point and a defined exit point, with the possibility to route via intermediate ...

As a Routes 360 member, you can feature a list of your unserved and underserved routes on your profile’s opportunity page for senior network planners from more than 190 airlines to consider.

Our Data and News subscriptions grant you access to our extensive databases for Commercial and Business Aviation. You can read our Exclusive News Stories, look up Aircraft Operators, analyse global ...

Administration routes are based on the medication used, how quickly it needs to be absorbed, and the part of the body where the medication needs to have an effect. Your healthcare provider or ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Exelixis (EXEL) reports results for the quarter ended December 2024. While this widely-known consensus outlook is ...

Among the innovators in this space, Exelixis, Inc. (EXEL) is gaining significant attention, and for good reason. Exelixis is zeroing in on difficult-to-treat cancers armed with a clinically ...